我国基本药物可及性实证研究  

Discussion of Empirical Study on Accessibility of Essential Drug in China

作　　者：张涛志[1] 王慧玲[2] 李健[2] 刘伟[3] 

机构地区：[1]郑州大学第二附属医院,郑州450014 [2]郑州铁路职业技术学院药学系,郑州450052 [3]郑州大学药学院,郑州450001

出　　处：《中国药房》2012年第28期2596-2598,共3页China Pharmacy

摘　　要：目的:为促进我国基本药物可及性提供参考。方法:采用文献调研的方法,通过各种数据库查询国内、外关于我国基本药物可及性实证研究的文献,并对其进行分析。结果:我国基本药物可及性的实证研究主要从可获得性(包括对基本药物认知情况的调查、利用和基本药物的生产供应情况等)、可负担性(通过世界卫生组织和国际健康行动机构提出的标准调查方法对基本药物的负担性的调查)、合理选择使用(通过对处方分析来调查研究基本药物的合理使用问题)等3个方面进行。结论:建议通过统计处方,筛选出我国基层医疗卫生机构临床首选的非基本药物,并将其与同类的基本药物进行循证药学和可负担性的比较研究,同时应加大对基本药物药品说明书在基本药物可及性中的重要作用的研究。OBJECTIVE：To provide reference for the improvement of the empirical study on accessibility of essential drug in China.METHODS：By literature research,querying the databases,domestic and foreign literatures about the empirical study on the accessibility of essential drug in China were analyzed.RESULTS：The empirical study on accessibility of the essential drug in China was conducted mainly from the three aspects of the availability（including surveys on cognition,utilization,production and supply situation of essential drug）,affordability（survey was conducted using the standard investigation method proposed by WHO and HAI） and the reasonable selection（survey was conducted through prescription analysis）.CONCLUSION：It is suggested to screen the non-essential medicines that primary healthcare facilities prefer to use in the clinic,and study on them with the corresponding essential drug through evidence-based pharmacy and affordability,with a purpose to provide reference for the adjustment of essential drug list in China and achieve the accessibility of the essential drug better;At the same time,the important role of package inserts of essential drug in the accessibility of essential drug should be studied.

关 键 词：基本药物 可及性 实证研究 

分 类 号：R95[医药卫生—药学]